Characterization of pulmonary and myocardial beta-adrenoceptors with S- 1'-[fluorine-18]fluorocarazolol

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 169-174

  Visser, Ton J ^b   Van Waarde, Aren ^a   Van Der Mark, Thom W ^b   Kraan, Jan ^b   Elsinga, Philip H ^b   Pruim, Jan ^b   Ensing, Kees ^b   Jansen, Twan ^b   Willemsen, Antoon T M ^b   Franssen, Eric J F ^b   Visser, Gerben M ^b   Paans, Anne M J ^b   Vaalburg, Willem ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

beta adrenoceptor density; fluorine 18 fluorocarazolol; PET

Indexed keywords

BETA ADRENERGIC RECEPTOR; PINDOLOL; SALBUTAMOL;

ADULT; ARTICLE; BINDING KINETICS; CONTROLLED STUDY; DRUG TISSUE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIGAND BINDING; LUNG ALVEOLUS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ALBUTEROL; CARBAZOLES; FEMALE; FLUORINE RADIOISOTOPES; HEART; HUMANS; LIGANDS; LUNG; MALE; MYOCARDIUM; PINDOLOL; PROPANOLAMINES; RADIOLIGAND ASSAY; RECEPTORS, ADRENERGIC, BETA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031053257     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 11C]carazolol, a radiotracer for the beta-adrenergic receptor. Nucl Med Biol 1992;19: 563-569.
2. Berridge MS, Nelson AD, Zheng LB, Leisure GP, Miraldi F. Specific beta-adrenergic receptor binding of carazolol measured with PET. J Nucl Med 1994;35:1665-1676.
3. 18F labeling of fluorocarazolol, a high-affinity beta-adrenergic receptor antagonist. J Med Chem 1994;37:3219-3230.
4. Francis BE, Eckelman WC, Grissom MP, Gibson RE, Reba RC. The use of tritium-labeled compounds to develop gamma-emitting receptor-binding radiotracers. Nucl Med Biol 1982;9:173-179.
5. 18F]fluorocarazolol in intact rats reflects radioligand binding to β-adrenoceptors. Eur J Pharmacol 1995;272:159-168.
6. 18F]fluorocarazolol, ligands for the visualization of pulmonary β-adrenergic receptors with PET. Nucl Med Biol 1996;23:159-167.
7. 18F]fluorocarazolol. Nucl Med Biol 1996:in press.
8. Bai TR, Mak JC, Barnes PJ. A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 1992;6:647-651.
9. Sharma RK, Jeffery PK. Airway beta-adrenoceptor number in cystic fibrosis and asthma. Clin Sci 1990;78:409-417.
10. Raaijmakers JA, Beneker C, Dol R, de Ruiter Bootsma AL. Decreased bronchiolar epithelial beta-adrenoceptor densities in patients with chronic obstructive lung disease. Cell Mol Biol 1987;33:515-518.
11. Bristow MR, Ginsburg R, Umans V, et al. Beta-1- and beta-2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta-1-receptor down-regulation in heart failure. Circ Res 1986;59:297-309.
12. Brodde OE. Beta1- and beta2-adrenoceptors in the human heart: properties, function and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-242.
13. Lopes AA, Liberato MH, Brentani MM, Aiello VD, Riso AA, Ebaid M. Lung beta-adrenoceptors in pulmonary hypertension. A study of biopsy specimens in children with congenital heart disease. Chest 1991;99:637-641.
14. Van Waarde A, Meeder JG, Blanksma PK, et al. Suitability of CGP12177 and CGP26505 for quantitative imaging of beta-adrenoceptors. Nucl Med Biol 1992;19: 711-718.
15. Van Waarde A, Meeder JG, Blanksma PK, et al. Uptake of radioligands by rat heart and lung in vivo: CGP12177 does and CGP26505 does not reflect binding to β-adrenoceptors. Eur J Pharmacol 1992;222:107-112.
16. Law MP. Demonstration of the suitability of CGP 12177 for in vivo studies of β-adrenoceptors. Br J Pharmacol 1993;109:1101-1109.
17. 11C CGP-12177 to assess beta-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993;87:1169-1178.
18. 11C]CGP-12177 and PET. J Appl Physiol 1993;75:559-565.
19. Delforge J, Syrota A, Lançon JP, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177 and a new graphical method. J Nucl Med 1991;32:739-748.
20. Valette H, Deleuze P, Syrota A, Delforge J, Crouzel C, Fuseau C, Loisance D. Canine myocardial beta-adrenergic, muscarinic receptor densities after denervation: a PET study. J Nucl Med 1995;36:140-146.
21. Cockroft DW, Killian DN, Mellon JJA, Hargreaves FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7:235-243.
22. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness: Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6(suppl. 16):53-83.
23. 18F]-fluorocarazolol, in plasma of humans, rats and sheep. J Chromatogr 1996;678:253-260.
24. Merlet P, Delforge J, Syrota A, et al. Quantification of beta-adrenergic receptor concentration in human with positron emission tomography [Abstract]. J Nucl Med 1991;32:989.
25. Lefroy DC, De Silva R, Choudhury L, et al. Myocardial beta-adrenoceptor density is reduced in hypertrophic cardiomyopathy [Abstract]. Circulation 1992;86:I-246.
26. van Koppen CJ, Hermanussen MW, Verrijp KN, et al. Beta-adrenoceptors in human tracheal smooth muscle: characteristics of binding and relaxation. Life Sci 1987;40: 2561-2570.
27. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 1985;132:541-547.
28. Muzic RF, Nelson AD, Saidel GM, Miraldi F. Optimal experiment design for PET quantification of receptor concentration. IEEE Trans Med Imag 1996;15:2-12.
29. Staehelin M, Simons P, Jaeggi K, Wigger N. CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 1983;258:3496-3502.
30. 3H]CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch Pharmacol 1987;336:519-525.
31. Van Waarde A, Anthonio RL, Visser TJ, et al. Quantification of a carbon-11-labeled β-adrenoceptor ligand, S-(-)-CGP 12177, in plasma of humans and rats. J Chromatogr 1995;B 663:361-369.
32. 11C]-CGP12177 metabolism in rat, dog and man using solid phase extraction and HPLC. J Lab Compd Radiopharm 1992;31:518-520.